Applied DNA Sciences (NASDAQ:APDN ) | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
Applied DNA Sciences

BRIEF

published on 09/23/2025 at 14:35, 2 months 11 days ago

Applied DNA Presents Key Platforms at Industry Conferences

Biotherapeutics MRNA Summit Nucleic Acid Production CAR-TCR Summit LineaDNA Platform
PRESS RELEASE

published on 09/23/2025 at 14:30, 2 months 11 days ago

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences
Applied DNA Sciences announces participation at industry conferences showcasing nucleic acid production solutions for biotherapeutics. Highlighting LineaDNA and LineaIVT platforms

Applied DNA Sciences Biotherapeutics LineaDNA LineaIVT Nucleic Acid Production
BRIEF

published on 08/14/2025 at 22:15, 3 months 21 days ago

Applied DNA Sciences Reports Q3 Fiscal 2025 Results

Financial Performance Applied DNA LineaRx Q3 2025 Results Synthetic DNA
PRESS RELEASE

published on 08/14/2025 at 22:10, 3 months 21 days ago

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results
Applied DNA Sciences, Inc. reports financial results for fiscal third quarter 2025, transitioning to synthetic DNA and mRNA manufacturing for advanced biotherapeutics and diagnostics

Financial Results Applied DNA Sciences Biotherapeutics MRNA Manufacturing Synthetic DNA
BRIEF

published on 07/24/2025 at 15:05, 4 months 11 days ago

Applied DNA Secures Follow-On Order for LineaDNA in Cancer Diagnostics

Applied DNA Sciences Cancer Diagnostics IVD Manufacturer Synthetic DNA LineaDNA
PRESS RELEASE

published on 07/24/2025 at 15:00, 4 months 11 days ago

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application
Applied DNA Sciences secured a $600,000 order for LineaDNA™ from a global IVD manufacturer. LineaDNA™ & LineaIVT™ are cutting-edge DNA production platforms

Applied DNA Sciences IVD Manufacturer LineaDNA LineaIVT DNA Production
BRIEF

published on 06/30/2025 at 15:05, 5 months 4 days ago

Applied DNA Sciences Restructures to Focus on Synthetic DNA Manufacturing

Cost Reduction Biotherapeutics Workforce Reduction Synthetic DNA LineaRx Focus
PRESS RELEASE

published on 06/30/2025 at 15:00, 5 months 4 days ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
Applied DNA Sciences, Inc. undergoes workforce reduction to focus on LineaRx synthetic DNA manufacturing. Ceases operations at Applied DNA Clinical Labs. Strategic decisions for growth and operational efficiency

Operational Efficiency Applied DNA Sciences Workforce Reduction LineaRx Synthetic DNA Manufacturing
BRIEF

published on 06/16/2025 at 15:05, 5 months 18 days ago

Applied DNA Sciences to Restart Quarterly Investor Calls

Financial Results Biotechnology Applied DNA Sciences PCR-based Technologies Quarterly Investor Calls
PRESS RELEASE

published on 06/16/2025 at 15:00, 5 months 18 days ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
Applied DNA Sciences, Inc. announces the resumption of quarterly investor calls starting mid-August 2025, cancelling the June 17th call. The company focuses on PCR-based DNA technologies

Financial Results Biotechnology Applied DNA Sciences PCR-based DNA Technologies Investor Calls

1 2 ... 5

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 28 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 33 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 3 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 58 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 3 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 1 hour 2 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 32 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 12 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 37 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 48 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 3 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 18 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 19 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE